Press Releases Agentix Corp.

Equities

AGTX

US00848A1034

Market Closed - OTC Markets Other stock markets 11:39:03 06/05/2024 pm IST			5-day change	1st Jan Change
0.023 ^USD	-28.57%		-28.57%	-25.81%

14/02	Agentix Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Agentix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AGENTIX CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/23/14	AQ
AGENTIX CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/22/14	AQ
AGENTIX CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	12/22/12	AQ
AGENTIX CORP. - 10-KT - Management's Discussion and Analysis Of Financial Condition and Results of Operations.	18/22/18	AQ
AGENTIX CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	15/22/15	AQ
AGENTIX CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	13/22/13	AQ
Happening Today: Agentix Corp. Presenting At The Emerging Growth Conference At 10:30am EST; Highlighting Clinical-Stage Developments and 2022 Initiatives	17/22/17	AQ
Agentix Corp. to Present at the Emerging Growth Conference on February 16, 2022 at 10:30am EST; Highlighting Clinical-Stage Developments and 2022 Initiatives	14/22/14	AQ
AGENTIX CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	13/22/13	AQ
AGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day Podcast	04/22/04	NE
AGENTIX CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22/21/22	AQ
AGENTIX : Management's Discussion and Analysis Of Financial Condition and Results of Operations. (form 10-K)	08/21/08	AQ
AGENTIX Corp. Stock Surges 27% On NHRI Licensing Deal To Treat Obesity and Type 2 Diabetes (OTC Pink: AGTX)	09/21/09	AQ
AGENTIX CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)	16/21/16	AQ
AGENTIX CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	15/21/15	AQ
AGENTIX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	10/21/10	AQ
AGENTIX CORP. : Change in Directors or Principal Officers (form 8-K)	05/21/05	AQ
Agentix Corp :. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021	02/21/02	AQ
AGENTIX CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	27/21/27	AQ
AGENTIX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	30/21/30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Agentix Corp.

Equities

AGTX

US00848A1034

Press Releases

Filters